Delta opioid receptors in Nav1.8 expressing peripheral neurons partially regulate the effect of delta agonist in models of migraine and opioid-induced hyperalgesia
Migraine is one of the most common pain disorders and causes disability in millions of people every year. Delta opioid receptors (DOR) have been identified as a novel therapeutic target for migraine and other headache disorders. DORs are present in both peripheral and central regions and it is uncle...
Main Authors: | Zachariah Bertels, Isaac J. Dripps, Pal Shah, Laura S. Moye, Alycia F. Tipton, Kendra Siegersma, Amynah A. Pradhan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-08-01
|
Series: | Neurobiology of Pain |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452073X22000162 |
Similar Items
-
PACAP-PAC1 receptor inhibition is effective in opioid induced hyperalgesia and medication overuse headache models
by: Zachariah Bertels, et al.
Published: (2023-02-01) -
Neuronal complexity is attenuated in preclinical models of migraine and restored by HDAC6 inhibition
by: Zachariah Bertels, et al.
Published: (2021-04-01) -
Calcitonin gene-related peptide causes migraine aura
by: Haidar M. Al-Khazali, et al.
Published: (2023-09-01) -
Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study
by: Todd J. Schwedt, et al.
Published: (2018-05-01) -
Study on “Atypical” Migraine Auras in the Pediatric Age: The Role of Cortical Spreading Depression and the Physiopathogenetic Hypothesis Arising from Our Clinical Cases
by: Vincenzo Raieli, et al.
Published: (2022-03-01)